Keyphrases
Adverse Effects
25%
Bone Development
25%
Bone Growth
25%
Bone Homeostasis
25%
Bone Remodeling
25%
Bone Volume Fraction
100%
Calves
50%
Cellular Senescence
25%
Clinical Signs
25%
Collagen Content
25%
Collagen Type I
25%
COX-2 Inhibitors
25%
Degree of Anisotropy
25%
Distal Tibia
50%
Duration Distribution
25%
Early Development
50%
Early Juvenile
100%
Embryonic Development
25%
Gait
75%
Growing pigs
25%
Growth Rate
25%
Hoof
25%
Hypoxia
50%
Juvenile Phase
100%
Limb Length
25%
Limb Loading
25%
Locomotor System
100%
Long-term Administration
25%
Meloxicam
25%
Micro-CT Imaging
25%
Multinucleated Cells
25%
Negative Effects
25%
Osteochondrosis
25%
Osteoclast
100%
Osteoclastogenesis
50%
Precocial
100%
Preferred Speed
25%
Pressure Distribution
25%
Prostaglandin Production
25%
Prostaglandins
25%
Resorption
50%
Senescence
25%
Shetland Pony
25%
Skeletal Development
25%
Speed Increase
25%
Stance Duration
25%
Stride Length
25%
Subchondral Bone
25%
Sudden Change
25%
Talus
50%
Tissue Remodeling
25%
Trabecular Bone
75%
Trabecular Bone Volume
50%
Trabecular Orientation
25%
Trabecular Thickness
25%
Variability Reduction
25%
Warmblood
25%
Agricultural and Biological Sciences
Adverse Effects
25%
Bone Growth
25%
Cell Cycle
25%
Cellular Senescence
25%
Early Development
50%
Embryogenesis
25%
Equus
25%
Foal
100%
Homeostasis
25%
Hooves
25%
Hypoxemia
50%
Meloxicam
25%
Micro-Computed Tomography
25%
Musculoskeletal System
100%
Osteoclast
100%
Pig
50%
Prostaglandin
50%
Shetland Pony
25%
Skeletal Development
25%
Skeleton
50%
Tibia
50%
Veterinary Science and Veterinary Medicine
Bone Growth
25%
Cancellous Bone
75%
Clinical Signs
25%
COX-2 Inhibitor
25%
Distal Tibia
50%
Foal
100%
Hooves
25%
Meloxicam
25%
Osteochondrosis
25%
Osteoclast
100%
Prostaglandin
50%
Shetland Pony
25%
Subchondral Bone
25%
Trabecula
25%
Warmblood
25%
Neuroscience
Adverse Effect
25%
Anisotropy
25%
Cell Cycle
25%
Cellular Senescence
25%
Collagen Type 1
25%
COX-2 Inhibitor
25%
Meloxicam
25%
Musculoskeletal System
100%
Osteoclast
100%
Prostaglandin
50%